|
|
|
|
|
HONG KONG, Sept 8, 2015 - (ACN Newswire) - Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group;" HKEx code: 690) is pleased to announce that the Group's chemical manufacturing line in Beijing has successfully passed the inspection under "Good Manufacturing Practice (2010 revision)"("GMP 2010") and received the Certificate of GMP for pharmaceutical products issued by China Food and Drug Administration ("CFDA") on 17 August 2015.
Mr. Kingsley LEUNG, Executive Director of Uni-Bio Science, said, "Upgrading to the latest GMP manufacturing standard will provide a number of advantages to the Group, including ensuring freedom to operate, improving product quality and upgrading manufacturing capacity, etc. In addition, we believe the upgrade will provide opportunities for the Group to acquire additional drug licenses to strengthen its competitive position in the industry."
It is a requirement by the CFDA for all industry participants to upgrade their manufacturing facilities to meet the new GMP 2010 standards by the end of 2015. The new standards closely mirror the standards of the European Medicines Agency. Together with the Group's Shenzhen facility, which has already achieved the GMP 2010 certification in 2013, all of the Group's manufacturing lines are new GMP ready. This achievement is an assertion of the Group's strength in producing high quality drugs, ensuring efficacious and safe products for our patients.
Contact:
Strategic Financial Relations Limited
Veron Ng Phone: +852 2864 4831 Email: veron.ng@sprg.com.hk
Angelus Lau Phone: +852 2864 4805 Email: angelus.lau@sprg.com.hk
Caley Chan Phone: +852 2114 4950 Email: caley.chan@sprg.com.hk
Fax: +852 2527 1196
Topic: Press release summary
Source: Uni-Bio Science Group Limited
Sectors: Daily News, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
